UBS Group
EUCR

UBS Group’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

UBS Group’s Portfolio EUCR Stock Details EUCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$34.8K Sell
2022
Q3 		$39K Buy
2022
Q2 		$22K Sell
2022
Q1 		$25K Buy
2021
Q4 		$4K Sell
2021
Q3 		$24K Sell
2021
Q2 		$37K Sell
2021
Q1 		$39K Buy